Header cover image

Hong Kong (HSI) Pharma Industry Analysis

UpdatedAug 11, 2022
DataAggregated Company Financials
  • 7D0.9%
  • 3M2.5%
  • 1Y-37.0%
  • YTD-23.4%

Over the last 7 days, the Pharma industry has risen 4.8%, driven by gains from CSPC Pharmaceutical Group of 3.4%. In the past year, the industry is down 37%. As for the next few years, earnings are expected to grow by 5.2% per annum.

Industry Valuation and Performance

Has the Hong Kong Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 11 Aug 2022HK$582.4bHK$512.8bHK$51.9b7.5x11.2x1.1x
Sat, 09 Jul 2022HK$658.1bHK$514.7bHK$52.2b8.9x12.6x1.3x
Mon, 06 Jun 2022HK$565.5bHK$515.9bHK$52.1b8.8x10.8x1.1x
Wed, 04 May 2022HK$577.6bHK$516.4bHK$51.8b8.2x11.2x1.1x
Fri, 01 Apr 2022HK$646.4bHK$523.8bHK$47.3b8.4x13.7x1.2x
Sun, 27 Feb 2022HK$650.5bHK$499.3bHK$44.1b9.8x14.7x1.3x
Tue, 25 Jan 2022HK$715.1bHK$497.7bHK$43.9b9.6x16.3x1.4x
Thu, 23 Dec 2021HK$699.1bHK$496.9bHK$43.8b9.4x16x1.4x
Sat, 20 Nov 2021HK$693.2bHK$495.7bHK$43.4b9.4x16x1.4x
Mon, 18 Oct 2021HK$730.1bHK$490.8bHK$42.6b10.2x17.2x1.5x
Wed, 15 Sep 2021HK$771.9bHK$489.5bHK$42.4b11.1x18.2x1.6x
Fri, 13 Aug 2021HK$873.9bHK$489.5bHK$42.4b11.9x20.6x1.8x
Tue, 08 Jun 2021HK$1.1tHK$463.7bHK$30.0b15.3x36.1x2.3x
Mon, 01 Mar 2021HK$953.9bHK$439.3bHK$27.7b12.4x34.4x2.2x
Thu, 03 Dec 2020HK$843.3bHK$424.8bHK$25.2b15x33.5x2x
Sun, 06 Sep 2020HK$853.8bHK$407.8bHK$27.1b17.1x31.5x2.1x
Wed, 10 Jun 2020HK$728.0bHK$416.7bHK$27.5b14.6x26.5x1.7x
Tue, 03 Mar 2020HK$720.7bHK$429.4bHK$27.1b14x26.6x1.7x
Fri, 06 Dec 2019HK$672.5bHK$416.3bHK$34.1b11.8x19.7x1.6x
Mon, 09 Sep 2019HK$720.7bHK$414.0bHK$34.7b11.9x20.7x1.7x
Price to Earnings Ratio


Total Market Cap: HK$720.7bTotal Earnings: HK$34.7bTotal Revenue: HK$414.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Pharma Industry Price to Earnings3Y Average 23.5x202020212022
Current Industry PE
  • Investors are pessimistic on the Hong Kong Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.5x which is lower than its 3-year average PE of 23.5x.
  • The 3-year average PS ratio of 1.7x is higher than the industry's current PS ratio of 1.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 14% per year over the last three years.
  • Revenues for these companies have grown 7.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Hong Kong Pharma compare with similar industries?

HK Market-0.65%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1093 CSPC Pharmaceutical GroupHK$8.554.3%
867 China Medical System HoldingsHK$12.828.8%
3692 Hansoh Pharmaceutical GroupHK$16.101.8%
1177 Sino BiopharmaceuticalHK$4.471.4%
6185 CanSino BiologicsHK$65.156.8%
Simply Wall St‚ĄĘ
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News